DiaMedica Therapeutics Inc.(DMAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DMAC DiaMedica Therapeutics Inc.

休市中 11-01 16:00:00 EDT

4.25

-0.12

-2.75%

盘后4.25

+0.000.00%

16:00 EDT

最高4.40	最低4.05	成交量6.94万
今开4.39	昨收4.37	日振幅8.01%
总市值1.82亿	流通市值1.12亿	总股本4,275万
成交额28.82万	换手率0.26%	流通股本2,626万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DMAC","market":"US","secType":"STK","nameCN":"DiaMedica Therapeutics Inc.","latestPrice":4.25,"timestamp":1730491200000,"preClose":4.37,"halted":0,"volume":69362,"hourTrading":{"tag":"盘后","latestPrice":4.25,"preClose":4.25,"latestTime":"16:00 EDT","volume":106,"amount":450.5,"timestamp":1730491208719},"delay":0,"floatShares":26264738,"shares":42747832,"eps":-0.523622,"marketStatus":"休市中","marketStatusCode":7,"change":-0.12,"latestTime":"11-01 16:00:00 EDT","open":4.3899,"high":4.4,"low":4.05,"amount":288226.299904,"amplitude":0.080092,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.523622,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730710800000},"adr":0,"listingDate":1544158800000,"adjPreClose":4.37,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":4.25,"preClose":4.25,"latestTime":"16:00 EDT","volume":106,"amount":450.5,"timestamp":1730491208719},"volumeRatio":2.0025984617281374,"impliedVol":0.7041,"impliedVolPercentile":0.2738},"requestUrl":"/m/hq/s/DMAC/wiki","defaultTab":"wiki","newsList":[{"id":"2468582619","title":"Diamedica Therapeutics Inc.盘中异动 急速下挫5.98%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468582619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468582619?lang=zh_cn&edition=full","pubTime":"2024-09-18 22:06","pubTimestamp":1726668361,"startTime":"0","endTime":"0","summary":"北京时间2024年09月18日22时06分，Diamedica Therapeutics Inc.股票出现异动，股价快速跳水5.98%。截至发稿，该股报4.09美元/股，成交量1.5506万股，换手率0.04%，振幅3.17%。Diamedica Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Diamedica Therapeutics Inc.公司简介：DiaMedica Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091822060198e37e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091822060198e37e78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DMAC"],"gpt_icon":0},{"id":"2467740497","title":"Diamedica Therapeutics Inc.盘中异动 早盘股价大涨5.71%报4.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467740497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467740497?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:44","pubTimestamp":1726238648,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日22时44分，Diamedica Therapeutics Inc.股票出现异动，股价大幅上涨5.71%。截至发稿，该股报4.54美元/股，成交量3.86万股，换手率0.09%，振幅6.29%。Diamedica Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immuneering Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为782.28%、333.91%、83.09%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immuneering Corporation、Prelude Therapeutics Incorporated，振幅分别为43.56%、42.66%、36.34%。Diamedica Therapeutics Inc.公司简介：DiaMedica Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322440898e378cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322440898e378cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DMAC","BK4139"],"gpt_icon":0},{"id":"2460414502","title":"Diamedica Therapeutics Inc.2024财年第二财季实现净利润-5.12百万美元，同比减少14.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460414502","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460414502?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824032,"startTime":"0","endTime":"0","summary":"8月17日，Diamedica Therapeutics Inc.公布财报，公告显示公司2024财年第二财季净利润为-5.12百万美元，同比减少14.29%；其中营业收入为0.00美元，每股基本收益为-0.13美元。从资产负债表来看，Diamedica Therapeutics Inc.总负债3.38百万美元，其中短期债务100000.00美元，资产负债比为16.81，流动比率为17.81。机构评级：截至2024年8月17日，当前有3家机构对Diamedica Therapeutics Inc.目标价做出预测，其中目标均价为7.00美元，其中最低目标价为6.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000504959f2c2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000504959f2c2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMAC","LENZ"],"gpt_icon":0},{"id":"2457030425","title":"DiaMedica Therapeutics Inc    预计每股亏损 16 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457030425","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457030425?lang=zh_cn&edition=full","pubTime":"2024-08-06 10:01","pubTimestamp":1722909700,"startTime":"0","endTime":"0","summary":"   * DiaMedica Therapeutics Inc    将于8月7日公布截至2024年6月30日的财报，预计季度营收将保持不变。*    * LSEG分析师对DiaMedica Therapeutics Inc的平均预期是每股亏损16美分。* 华尔街对 DiaMedica Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其上次收盘价 3.45 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAC","LENZ"],"gpt_icon":0},{"id":"2456671541","title":"Diamedica Therapeutics Inc.盘中异动 股价大跌8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456671541","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456671541?lang=zh_cn&edition=full","pubTime":"2024-08-01 04:00","pubTimestamp":1722456052,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日04时00分，Diamedica Therapeutics Inc.股票出现波动，股价急速下跌8.03%。截至发稿，该股报3.32美元/股，成交量7.1915万股，换手率0.17%，振幅4.43%。Diamedica Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Windtree Therapeutics, Inc.、Molecular Partners Ag、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为834.79%、180.82%、169.09%，振幅较大的相关个股有Molecular Partners Ag、Renovaro Inc.、Windtree Therapeutics, Inc.，振幅分别为89.73%、79.10%、63.20%。Diamedica Therapeutics Inc.公司简介：DiaMedica Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801040053af9529dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801040053af9529dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DMAC","BK4139"],"gpt_icon":0},{"id":"2450808326","title":"Diamedica Therapeutics Inc.盘中异动 下午盘大幅上涨6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450808326","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450808326?lang=zh_cn&edition=full","pubTime":"2024-07-09 01:17","pubTimestamp":1720459059,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日01时17分，Diamedica Therapeutics Inc.股票出现波动，股价快速上涨6.90%。截至发稿，该股报3.10美元/股，成交量5.9846万股，换手率0.14%，振幅5.52%。Diamedica Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Diamedica Therapeutics Inc.公司简介：DiaMedica Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709011739af911b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709011739af911b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMAC","BK4139","LENZ"],"gpt_icon":0},{"id":"2446522145","title":"Diamedica Therapeutics Inc.盘中异动 临近午盘股价大跌6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446522145","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446522145?lang=zh_cn&edition=full","pubTime":"2024-06-27 23:36","pubTimestamp":1719502566,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日23时36分，Diamedica Therapeutics Inc.股票出现波动，股价急速下挫6.42%。Diamedica Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Diamedica Therapeutics Inc.公司简介：DiaMedica Therapeutics Inc是一家临床阶段的生物制药公司。消息层面，截至23时36分，《Lake Street维持DiaMedica Therapeutics买入评级，维持目标价7美元》资讯为影响Diamedica Therapeutics Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627233606aef6f3ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627233606aef6f3ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMAC","BK4139","LENZ"],"gpt_icon":0},{"id":"2445794333","title":"Diamedica Therapeutics Inc.盘中异动 大幅跳水5.26%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445794333","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445794333?lang=zh_cn&edition=full","pubTime":"2024-06-22 04:01","pubTimestamp":1719000091,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日04时01分，Diamedica Therapeutics Inc.股票出现异动，股价大幅跳水5.26%。截至发稿，该股报2.16美元/股，成交量2.3968万股，换手率0.06%，振幅4.65%。Diamedica Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Diamedica Therapeutics Inc.公司简介：DiaMedica Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622040131aef61079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622040131aef61079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DMAC"],"gpt_icon":0},{"id":"2436468269","title":"Diamedica Therapeutics Inc.2024财年第一财季实现净利润-5.15百万美元，同比增加2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436468269","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436468269?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:20","pubTimestamp":1715962803,"startTime":"0","endTime":"0","summary":"3月31日，Diamedica Therapeutics Inc.公布财报，公告显示公司2024财年第一财季净利润为-5.15百万美元，同比增加2.28%；其中营业收入为0.00美元，每股基本收益为-0.14美元。从资产负债表来看，Diamedica Therapeutics Inc.总负债2.91百万美元，其中短期债务86000.00美元，资产负债比为16.93，流动比率为18.13。机构评级：截至2024年3月31日，当前有3家机构对Diamedica Therapeutics Inc.目标价做出预测，其中目标均价为7.00美元，其中最低目标价为6.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800201387750a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800201387750a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DMAC","LENZ"],"gpt_icon":0},{"id":"2433789745","title":"Diamedica Therapeutics Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789745","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433789745?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:58","pubTimestamp":1715093908,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时58分，Diamedica Therapeutics Inc.股票出现异动，股价大幅上涨5.14%。截至发稿，该股报3.68美元/股，成交量6.1477万股，换手率0.16%，振幅2.86%。Diamedica Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Diamedica Therapeutics Inc.公司简介：DiaMedica Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722582987e8624e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722582987e8624e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DMAC","LENZ"],"gpt_icon":0},{"id":"2433792239","title":"DiaMedica Therapeutics Inc    预计每股亏损 16 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433792239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433792239?lang=zh_cn&edition=full","pubTime":"2024-05-07 05:03","pubTimestamp":1715029381,"startTime":"0","endTime":"0","summary":"   * DiaMedica Therapeutics Inc    将于5月8日公布截至2024年3月31日的财报，预计该公司的季度收入将保持不变。*    * LSEG分析师对DiaMedica Therapeutics Inc的平均预期是每股亏损16美分。* 华尔街对 DiaMedica Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其上次收盘价 3.00 美元。5月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","DMAC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.diamedica.com","stockEarnings":[{"period":"1week","weight":-0.0319},{"period":"1month","weight":-0.0449},{"period":"3month","weight":0.284},{"period":"6month","weight":0.4167},{"period":"1year","weight":0.864},{"period":"ytd","weight":0.4965}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Diamedica Therapeutics Inc.最初是根据《公司法》（马尼托巴省）于2000年1月21日通过公司章程成立的。2019年5月31日，从根据CBCA成立的公司继续存在到根据BCBCA成立的不列颠哥伦比亚省。该公司是一家临床阶段的生物制药公司，致力于改善患有严重疾病的人的生活。Diamedica疗法的主要候选药物DM199是第一个在患者中研究的具有药物活性的重组（合成）形式的人体组织激肽释放酶-1（KLK1）蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.071352},{"month":2,"riseRate":0.833333,"avgChangeRate":0.066574},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.044865},{"month":4,"riseRate":0.5,"avgChangeRate":0.012305},{"month":5,"riseRate":0.666667,"avgChangeRate":0.110547},{"month":6,"riseRate":0.666667,"avgChangeRate":0.220348},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.150502},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002116},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.139813},{"month":10,"riseRate":0.5,"avgChangeRate":0.04107},{"month":11,"riseRate":0.666667,"avgChangeRate":0.070051},{"month":12,"riseRate":0.8,"avgChangeRate":0.367894}],"exchange":"NASDAQ","name":"DiaMedica Therapeutics Inc.","nameEN":"DiaMedica Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DiaMedica Therapeutics Inc.(DMAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DiaMedica Therapeutics Inc.(DMAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DiaMedica Therapeutics Inc.,DMAC,DiaMedica Therapeutics Inc.股票,DiaMedica Therapeutics Inc.股票老虎,DiaMedica Therapeutics Inc.股票老虎国际,DiaMedica Therapeutics Inc.行情,DiaMedica Therapeutics Inc.股票行情,DiaMedica Therapeutics Inc.股价,DiaMedica Therapeutics Inc.股市,DiaMedica Therapeutics Inc.股票价格,DiaMedica Therapeutics Inc.股票交易,DiaMedica Therapeutics Inc.股票购买,DiaMedica Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DiaMedica Therapeutics Inc.(DMAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DiaMedica Therapeutics Inc.(DMAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}